Experience
Medicis Pharmaceutical Corp.
Apotex, Inc.
Represented Medicis in Hatch-Waxman patent infringement litigation concerning an ANDA for generic versions of Solodyn®.
Medicis Pharmaceutical Corp. v. Apotex, Inc., 1:15-cv-02676, D.N.J., Judges Kugler, Schneider
Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.
Medicis Pharmaceutical Corp.
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
Otsuka Pharmaceutical Co., Ltd.
Shionogi Pharmaceuticals v. Apotex/Sandoz
Shionogi Pharmaceuticals
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
Valeant; Salix; Progenics
Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc.
Dow Pharmaceutical Sciences, Inc.
Acorda Therapeutics, Inc. v. Apotex Inc.
Acorda Therapeutics, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.